TrialJournal of gastroenterology2017
Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma.
Kenji Ikeda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
186 papers cite itlatest 60 shown
this paperpooled ittrialcites it